Welcome to the press section. If you want to be included in our media database, please send us an email.
Filter Press releases:
22 February 2023
BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment
Read press release
8 February 2023
Structural proteins for the development of sustainable materials: BRAIN Biotech and AMSilk cooperate to develop high-performance bio-based protein fibers
Read press release
16 January 2023
BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment
Read press release
10 January 2023
BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
Read press release
9 January 2023
Key Leadership Appointments at BRAIN Biotech AG, Zwingenberg Site
Read press release
17 November 2022
MP Beteiligungs-GmbH Increases Stake in BRAIN Biotech AG
Read press release
25 October 2022
BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides
Read press release
27 September 2022
Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand
Read press release
26 September 2022
BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company
Read press release
29 August 2022
BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
